Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Abattis Bioceuticals (ATTBF)

Abattis Bioceuticals (ATTBF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.46
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0030 +23.33%
on 12/12/19
0.0099 -62.63%
on 11/25/19
-0.0055 (-59.78%)
since 11/13/19
3-Month
0.0030 +23.33%
on 12/12/19
0.0250 -85.20%
on 09/16/19
-0.0192 (-83.84%)
since 09/13/19
52-Week
0.0025 +48.00%
on 08/01/19
0.0900 -95.89%
on 02/15/19
-0.0725 (-95.14%)
since 12/13/18

Most Recent Stories

More News
Abattis Announces Acquisition of European Nutraceutical Company and Provides Corporate Updates

VANCOUVER, British Columbia, April 2, 2019 /PRNewswire/ -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE: ATT) is pleased to announce that its wholly-owned subsidiary, 1185277 B.C. Ltd....

ATTBF : 0.0037 (-5.13%)
ATT.CN : 0.080 (unch)
Abattis Announces Acquisition of European Nutraceutical Company and Provides Corporate Updates

ATTBF : 0.0037 (-5.13%)
Abattis Announces Acquisition of European Nutraceutical Company and Provides Corporate Updates

Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE: ATT) (OTC: ATTBF) is pleased to announce that its wholly-owned subsidiary, 1185277 B.C. Ltd. (the "Acquisition Subsidiary"), has entered into...

ATT.CN : 0.080 (unch)
ATTBF : 0.0037 (-5.13%)
Abattis Announces Resignation of Directors

Vancouver, British Columbia--(Newsfile Corp. - March 9, 2019) - (CSE: ATT) (OTC Pink: ATTBF) (the "" or "") announces that, effective February 20, 2019 and March 6, 2019, both Wolfgang Richter and James...

ATTBF : 0.0037 (-5.13%)
ATT.CN : 0.080 (unch)
Abattis Provides Update on Trading Halt and Announces Management Conference Call

Abattis Bioceuticals Corp (the "Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to provide the following update on the Company's recent trading halt and upcoming conference call with Company management...

ATT.CN : 0.080 (unch)
ATTBF : 0.0037 (-5.13%)
Abattis Removed From BCSC Temporary Order

Abattis Bioceuticals Corp (the "Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to announce that the temporary order from the British Columbia Securities Commission ("BCSC"), issued on November...

ATT.CN : 0.080 (unch)
ATTBF : 0.0037 (-5.13%)
Abattis Enters Into Definitive Share Exchange Agreement With NutriVida

Abattis Bioceuticals Corp (the "Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to announce that, further to its new release dated December 7, 2018, the Company has entered into a definitive share...

ATT.CN : 0.080 (unch)
ATTBF : 0.0037 (-5.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade ATTBF with:

Key Turning Points

2nd Resistance Point 0.0042
1st Resistance Point 0.0040
Last Price 0.0037
1st Support Level 0.0034
2nd Support Level 0.0030

See More

52-Week High 0.0900
Fibonacci 61.8% 0.0566
Fibonacci 50% 0.0463
Fibonacci 38.2% 0.0359
Last Price 0.0037
52-Week Low 0.0025

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar